Contact this trialFirst, we need to learn more about you.
Prostacyclin Analogue
Inhaled Treprostinil for Pulmonary Hypertension
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial is testing the effectiveness of treprostinil, given via inhaler, on patients with pulmonary arterial hypertension related to interstitial lung disease. The study will track exercise capacity and quality of life after 3 months.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.